Communicating THC levels and ‘dose’ to consumers: Implications for product labelling and packaging of cannabis products in regulated markets
Author:
- 1 May 2021
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 91, 102509
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 35 references indexed in Scilit:
- Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effectsBritish Journal of Pharmacology, 2011
- Health warning messages on tobacco products: a reviewTobacco Control, 2011
- Illicit drugs policy through the lens of regulationInternational Journal of Drug Policy, 2010
- A Comparison of Mainstream and Sidestream Marijuana and Tobacco Cigarette Smoke Produced under Two Machine Smoking ConditionsChemical Research in Toxicology, 2007
- Human Cannabinoid PharmacokineticsChemistry & Biodiversity, 2007
- Long term marijuana users seeking medical cannabis in California (2001–2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicantsHarm Reduction Journal, 2007
- Pharmacokinetics and Pharmacodynamics of CannabinoidsClinical Pharmacokinetics, 2003
- Harm Reduction Associated with Inhalation and Oral Administration of Cannabis and THCJournal of Cannabis Therapeutics, 2001
- General Performance on a Numeracy Scale among Highly Educated SamplesMedical Decision Making, 2001
- Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resinJournal of Pharmacy and Pharmacology, 1984